Common use of Study Results Clause in Contracts

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO and Pfizer encourage Principal Investigator to communicate the results, as appropriate, to the Study Subjects. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with SUKL/the IRB/IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution. d.

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO and Pfizer encourage Principal Investigator to communicate the results, as appropriate, to the Study Subjects. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with SUKL/the IRB/IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution. d..

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO and Pfizer encourage encourages Principal Investigator to communicate the results, as appropriate, to the Study Subjects. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with the SUKL/the IRB/IEC relevant Ethics Committee, as appropriate, will cooperate with Principal Investigator or Institution Provider to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution. d.Provider.

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO , and Pfizer encourage Principal Investigator has agreed to communicate share this summary with the results, as appropriate, to the Study SubjectsHealth Services Provider. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with SUKL/the IRB/relevant IEC as appropriate, will cooperate with Principal Investigator or Institution the Health Services Provider to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institutionthe Health Services Provider. d.

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO , and Pfizer encourage Principal Investigator has agreed to communicate the results, as appropriate, to the Study Subjectsshare this summary with Institution. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with SUKL/the IRB/relevant IEC as appropriate, will cooperate with Principal Investigator or Institution to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution. d.appropriately

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO and Pfizer encourage encourages Principal Investigator to communicate the results, as appropriate, to the Study Subjects. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with the SUKL/the IRB/IEC relevant Ethics Committee, as appropriate, will cooperate with Principal Investigator or Institution Institute to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or InstitutionInstitute. d.11.2

Study Results. After analysis of Study Data from all sites is complete, CRO or Pfizer will provide Principal Investigator with a summary of the overall results of the Study. CRO , and Pfizer encourage Principal Investigator has agreed to communicate share this summary with the results, as appropriate, to the Study SubjectsHealth Services Provider. If within two years after Study completion Pfizer identifies results that could affect Study Subject safety, CRO or Pfizer, in consultation with SUKL/the IRB/relevant IEC as appropriate, will cooperate with Principal Investigator or Institution the Health Services Provider to ensure that those results are appropriately communicated to the Study Subjects by Principal Investigator or Institution. d.the Health Services Provider.